ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Carolina » Clinical Cardiac Electrophysiology

Top Clinical Cardiac Electrophysiology Prescribers in North Carolina

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
DAVID FRAZIER MD

Clinical Cardiac Electrophysiology

5,575

$463K

609
480 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $59

ALI AKBARY M.D.

Clinical Cardiac Electrophysiology

4,318

$170K

419
343 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$39
Average prescription price

Avg: $59

MARK MITCHELL MD

Clinical Cardiac Electrophysiology

3,956

$212K

474
428 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $59

MARK LANDERS MD

Clinical Cardiac Electrophysiology

3,844

$180K

386
315 are 65+

15%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $59

STEVEN KLEIN M.D.

Clinical Cardiac Electrophysiology

3,529

$205K

444
373 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $59

GREGG TAYLOR M.D.

Clinical Cardiac Electrophysiology

3,269

$135K

371
308 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $59

SAMEH MOBAREK M.D.

Clinical Cardiac Electrophysiology

3,064

$237K

363
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 24%

$77
Average prescription price

Avg: $59

JAMES FOSTER M.D.

Clinical Cardiac Electrophysiology

2,841

$115K

299
234 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $59

ROBERT HANICH M.D.

Clinical Cardiac Electrophysiology

2,712

$110K

355
281 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$40
Average prescription price

Avg: $59

PRAFUL PATEL MD

Clinical Cardiac Electrophysiology

2,637

$193K

290
233 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 24%

$73
Average prescription price

Avg: $59

RANDOLPH COOPER M.D.

Clinical Cardiac Electrophysiology

2,398

$129K

362
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $59

WILLIAM SMITH M.D.

Clinical Cardiac Electrophysiology

2,392

$167K

292
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $59

HEMANTKUMAR PATEL MD

Clinical Cardiac Electrophysiology

2,340

$186K

299
256 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 24%

$80
Average prescription price

Avg: $59

JAMES FORRESTER M.D.

Clinical Cardiac Electrophysiology

2,276

$169K

222
175 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $59

LAI KOK MD

Clinical Cardiac Electrophysiology

2,243

$125K

314
269 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $59

JOHN BAILEY MD

Clinical Cardiac Electrophysiology

2,116

$108K

248
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

12%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $59

KEVIN HSU MD

Clinical Cardiac Electrophysiology

2,001

$112K

229
189 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $59

MICHAEL DRUCKER MD

Clinical Cardiac Electrophysiology

1,951

$115K

298
266 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 24%

$59
Average prescription price

Avg: $59

MARK KREMERS MD

Clinical Cardiac Electrophysiology

1,814

$83.1K

193
158 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

18%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 24%

$46
Average prescription price

Avg: $59

MICHAEL YARNOZ M.D.

Clinical Cardiac Electrophysiology

1,656

$96.4K

223
187 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 24%

$58
Average prescription price

Avg: $59

RODRIGO BOLANOS M.D.

Clinical Cardiac Electrophysiology

1,619

$99.7K

228
194 are 65+

7%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 24%

$62
Average prescription price

Avg: $59

OMER SHEDD MD

Clinical Cardiac Electrophysiology

1,578

$108K

249
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

10%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 24%

$68
Average prescription price

Avg: $59

JOHN ENGLEHARDT M.D.

Clinical Cardiac Electrophysiology

1,419

$85K

166
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $59

THOMAS WILEY M.D.

Clinical Cardiac Electrophysiology

1,351

$63.7K

199
162 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $59

KEVIN CAMPBELL M.D.

Clinical Cardiac Electrophysiology

1,197

$52.9K

199
171 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 24%

$44
Average prescription price

Avg: $59

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank